Phase i study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

Ronald C. Chen, Julian G. Rosenman, Leroy G. Hoffman, Wing Keung Chiu, Andrew Z. Wang, Raj S. Pruthi, Eric M. Wallen, Jeffrey M. Crane, William Y. Kim, W. Kimryn Rathmell, Paul A. Godley, Young E. Whang

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences